Venturi Wealth Management LLC acquired a new stake in Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 3,081 shares of the conglomerate’s stock, valued at approximately $267,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Peddock Capital Advisors LLC increased its position in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Motco increased its position in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC increased its position in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares in the last quarter. Integrated Investment Consultants LLC increased its position in Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock valued at $185,000 after buying an additional 393 shares in the last quarter. Finally, Cedar Wealth Management LLC increased its position in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares in the last quarter. Hedge funds and other institutional investors own 76.30% of the company’s stock.

Shares of Danaher Corporation (DHR) opened at 85.48 on Wednesday. The company has a market capitalization of $59.33 billion, a PE ratio of 26.05 and a beta of 1.05. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The firm’s 50-day moving average price is $84.77 and its 200 day moving average price is $84.18.

Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, April 20th. The conglomerate reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.84 by $0.01. The business had revenue of $4.21 billion for the quarter, compared to analyst estimates of $4.17 billion. Danaher Corporation had a net margin of 12.30% and a return on equity of 11.82%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company posted $1.08 earnings per share. On average, equities analysts forecast that Danaher Corporation will post $3.93 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Wednesday, June 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.02%.

ILLEGAL ACTIVITY WARNING: “Venturi Wealth Management LLC Invests $267,000 in Danaher Corporation (NYSE:DHR)” was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/venturi-wealth-management-llc-invests-267000-in-danaher-corporation-nysedhr/1451163.html.

Several research firms have recently commented on DHR. Credit Suisse Group reiterated a “buy” rating and issued a $93.00 price objective on shares of Danaher Corporation in a report on Wednesday, May 24th. Janney Montgomery Scott downgraded Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. Deutsche Bank AG reiterated a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a report on Wednesday, June 21st. Vetr upgraded Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price objective on the stock in a report on Thursday, April 20th. Finally, Cowen and Company reiterated an “outperform” rating and issued a $90.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $92.11.

In other news, insider Thomas Patrick Joyce, Jr. sold 54,006 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $82.52, for a total transaction of $4,456,575.12. Following the transaction, the insider now directly owns 142,157 shares of the company’s stock, valued at $11,730,795.64. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 82,265 shares of company stock worth $6,815,839. Corporate insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.